Posted 12/3/2016 7:21 PM (GMT 0)
peanut307-
I very much understand where you guys are at- I have had similar thoughts myself regarding BAT, mostly from viewpoint of improving QOL for someone on lifetime ADT (and with a very prominent "use by" date on the carton at that).
From one perspective, when you are told cure is no option and all care is palliative, then QOL becomes a central issue in trying to see a path going forward. So then, what does it matter if one wants to try off-label use of a very cheap drug that is showing promise under trial in certain conditions. Of course docs operate under the "first do no harm" clause- but chemotherapy and also ADT very often cause significant harm, so you are always balancing health cost vs effectiveness vs QOL- a very emotional and difficult equation- and hope is so important in getting on from day to day, we are always looking for nuggets of it in little corners on the web or in posts from others who share our fate. BAT sure offers a parcel of hope, and it seems so easy and cheap...
I am not advocating experimentation with BAT and a willing MO for others. That is not safe. But frankly, any palliative care is experimental (MO: "well, that treatment didn't work as I had hoped; sorry about the nasty SE though, let's try this if you are up for it..."). Even Zytiga does not work on some guys ("oooh, sorry about that nasty SE on your retirement account after 6 months on Zytiga. We need to move onto another therapy..."). The point I make here is that pretty much all CMS-approved PCa treatments are a numbers game (even ADT, but it has really good numbers for the transient effect it gives us). We just don't have any numbers for BAT at this time.
So I can see how it will never be a black and white issue (safe and proven vs not-yet-phase-III-trial-verified) for people with no hope of cure. And when we see some people clearly showing PSA stability and tumor regression in BAT trials, we wonder if it would work for each of us as well.
With regard to the numbers game for me, with data at hand, I am looking at median survival of six years, but I cannot fathom how a lot of Gleason 10 will impact that statistic, except I know it won't be in my favor. This disease will very likely kill me before I reach 70, and the last two years, the darkest of that stretch.. well I just don't think about that right now- plenty of time for that later, now is for the new sun each day and the joy that I can still work, think, and love.
But when I show castration resistance, I too will be wanting to have a conversation with my MO regarding BAT- regardless of the status of ongoing trials. If the setting is appropriate, than the risks I would take could approximate those I would encounter in a trial (an important point if previous therapies, or lack thereof, exclude me from a trial).
gosh that was not a "quick reply"- but keep at it you guys; sometimes the fight itself even gives us some hope
here's to fightin'
rf